An additional method for differentiating between Campylobacter fetus subsp. jejuni and C. fetus subsp. intestinalis is reported. Strains of C. fetus subsp. jejuni (18/20) were shown to hydrolyze hippurate in the 2-h rapid test, whereas strains of C. fetus subsp. intestinalis did not.
Differentiation between strains of the two subspecies of Campylobacter fetus recognized as human pathogens, subsp. intestinalis and subsp. jejuni, relies principally on two tests: (i) the ability of the organism to grow at 420C and (ii) the sensitivity of the organism to 30-,ug nalidixic acid disks. C. fetus subsp. jejuni is characterized by growth at 42°C and sensitivity to high-concentration nalidixic acid, whereas most strains of C. fetus subsp. intestinalis will not grow at 420C and show no zone of inhibition surrounding the disks (5) . Reliance on these two tests has been dictated by the limited metabolic properties exhibited by Campylobacter sp. Physiological studies (1, 4) have shown that tricarboxylic acid cycle intermediates and amino acids serve as primary energy sources for these organisms. No carbohydrates are utilized. It is the purpose of this report to describe an additional test, hippurate hydrolysis, which should prove useful in differentiating among these strains.
The rapid hippurate hydrolysis test was first described by Hwang and Ederer (3) for use in differentiating Streptococcus agalactiae (group B) from Streptococcus pyogenes (group A). One of the end products of the hydrolysis of hippurate, glycine, is detected in 2 h with ninhydrin. In the study reported here, this end product, glycine, was detected by thin-layer chromatography as well as the procedure of Hwang and Ederer.
For the rapid hippurate hydrolysis method (3), a 1% aqueous solution of sodium hippurate (Eastman) was prepared and dispensed in 0.4-ml amounts. Portions not used on the day of preparation were corked and frozen at -15°C until used. For the test, a large loopful of organisms from supplemented thioglycollate agar with 7% human blood was emulsified in the substrate. The thioglycollate agar is a modification of a medium described by George and colleagues (2) . This medium was autoclaved and cooled to 500C, and 7% human blood was added aseptically. Plates were inoculated and incubated 48 h before testing at 350C in GasPak jars (BBL Microbiology Systems) with the GasPak generator but without the catalyst. Group A and group B streptococci were included as negative and positive controls, respectively, for each experiment, as were aqueous suspensions of C. fetus subsp. jejuni, and C. fetus subsp. intestinalis, and an uninoculated substrate control. Tubes were incubated and read as described by Hwang and Ederer (3).
The substrate, method, and controls as described for the rapid hippurate hydrolysis test were also used for the thin-layer chromatography method. The only difference was that at the end of the organism-substrate incubation period, the tubes were centrifuged, and 2 
